6-K - Basel Medical Group Ltd Ordinary Shares | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Basel Medical Group Ltd appointed Mr. Tan Boon Chye (Darren), its Chief Commercial Officer, as a director, replacing Ms. Jianing Lu who resigned from the board on March 30, 2026.

Key Takeaways

1Mr. Tan Boon Chye (Darren) appointed as director on the board.

2Mr. Tan Boon Chye (Darren) is Chief Commercial Officer of Basel Medical Group Ltd.

3Ms. Jianing Lu resigned from the board of directors.

4Ms. Jianing Lu continues as Chief Financial Officer unaffected by resignation.

5Appointments and resignation occurred on the same day, March 30, 2026.

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Executive & Director Changes

Mr. Tan Boon Chye (Darren)

Director

Appointed

Effective: 2026-03-30

Ms. Jianing Lu

Director

Resigned

Effective: 2026-03-30

N/A

Exhibits (1)

6-K